With funding from Canadian Blood Services’ BloodTechNet Award Program, transfusion medicine specialists developed Learnserology.ca, an online curriculum that supports serology education.

How Canadian Blood Services quickly stood up a seroprevalence lab able to test thousands of donor blood samples for SARS-CoV-2 antibodies each day

Postponed in April 2020, the Centre for Blood Research’s annual Norman Bethune Symposium moved to an online format and was held on Sept. 9, 2020. We heard from some Canadian Blood Services research trainees about the symposium and their experiences presenting their work in the “new normal” virtual format, which included a research showcase via Twitter.

With their recent study, Centre for Innovation senior scientist Dr. Jason Acker and his international colleagues bring studying red blood cell shape into the 21st century.

The Centre for Innovation’s Dr. Heyu Ni has been honoured by induction into the Canadian Academy of Health Sciences. Considered one of the highest honours for Canadian academics, Dr. Ni’s election as a Fellow is a recognition of the excellence of his work as a leader in Canadian health sciences.

Transfusion Camp is an educational program established by the University of Toronto QUEST program that teaches physicians how to use blood wisely. When the COVID-19 pandemic hit, we questioned whether Transfusion Camp could continue.

In 1964, a seminal paper described the “waterfall” sequence of coagulation, representing a huge leap in our understanding of how blood clots. One of its authors, Dr. Earl W. Davie, a giant of blood coagulation research, died in June 2020 at the age of 92. We reflect on his legacy.

Dr. Isra Levy is in charge of medical and scientific support for all aspects of Canadian Blood Services’ work — how does he prepare for this job during a pandemic? To better understand what crisis leadership is, I asked Isra to share the lessons he has learned through his leadership journey.

A research team that includes experts from Canadian Blood Services and the McMaster Centre for Transfusion Research showed that genotyping red blood cell proteins could help make transfusions safer for patients with sickle cell disease.

COVID-19 has brought major implications for blood transfusion practices: uncertain demand patterns, reduced donations and loss of staff. A recent publication synthesizes studies that address the transfusion chain and provide guidance during times of potential or actual shortage. Dr. Mindy Goldman, medical director at Canadian Blood Services, is one of the study’s authors.